New study tracks meningitis vaccine safety in pregnancy
NCT ID NCT04843111
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study monitors the safety of the MenQuadfi vaccine when given to pregnant women or within 30 days before their last period. Researchers will track side effects in mothers and health outcomes in babies, including birth defects and complications. About 50 women in the U.S. will participate to help ensure the vaccine is safe during pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGOCOCCAL INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pennsylvania Locations
RECRUITINGSwiftwater, Pennsylvania, 18370-0187, United States